AG˹ٷ

STOCK TITAN

[SCHEDULE 13G] Invivyd, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Point72 group disclosed a passive 13G stake in Invivyd, Inc. The filing shows Point72 Asset Management, Point72 Capital Advisors and Steven A. Cohen beneficially own 16,730,467 shares, representing 8.0% of Invivyd's outstanding common stock based on 209,377,291 shares outstanding following the issuer's August 22, 2025 underwritten offering. The reported shares are held through Point72 Associates, LLC, with shared voting and dispositive power and no sole voting or dispositive power reported. The filing is submitted on a joint basis and states the position is not intended to influence control of the issuer.

Il gruppo Point72 ha dichiarato una partecipazione passiva 13G in Invivyd, Inc. La comunicazione indica che Point72 Asset Management, Point72 Capital Advisors e Steven A. Cohen beneficamente possiedono 16.730.467 azioni, pari al 8,0% del capitale sociale ordinario di Invivyd, calcolato su 209.377.291 azioni in circolazione dopo l'offerta sottoscritta dell'emittente del 22 agosto 2025. Le azioni segnalate sono detenute tramite Point72 Associates, LLC, con poteri condivisi di voto e di disposizione e senza poteri esclusivi di voto o di disposizione. La segnalazione è presentata congiuntamente e specifica che la posizione non è intesa a influenzare il controllo dell'emittente.

El grupo Point72 divulgó una participación pasiva 13G en Invivyd, Inc. La presentación muestra que Point72 Asset Management, Point72 Capital Advisors y Steven A. Cohen poseen de forma beneficiaria 16.730.467 acciones, que representan el 8,0% del capital social ordinario de Invivyd sobre la base de 209.377.291 acciones en circulación tras la oferta suscrita del emisor del 22 de agosto de 2025. Las acciones informadas se mantienen a través de Point72 Associates, LLC, con poder de voto y disposición compartidos y sin poder exclusivo de voto o disposición. La presentación se realiza de forma conjunta y declara que la posición no pretende influir en el control del emisor.

포인�72 그룹� 인비비드(Invivyd, Inc.)� 대� 수동� 13G 지분을 공시했습니다. 제출 서류� 따르� Point72 Asset Management, Point72 Capital Advisors � Steven A. Cohen은 � 16,730,467주를 실질적으� 보유하고 있으�, 이는 2025� 8� 22� 발행회사� 인수주식공개(언더라이터드 오퍼�) 이후 기준 발행주식� 209,377,291주를 기준으로 인비비드 보통� 발행주식� 8.0%� 해당합니�. 보고� 주식은 Point72 Associates, LLC� 통해 보유되며 투표권과 처분권은 공동으로 행사되며 단독 투표권이� 단독 처분권은 보고되지 않았습니�. � 제출은 공동으로 이루어졌으며 해당 지분이 발행회사� 지배에 영향� 미치려는 의도� 없다� 명시하고 있습니다.

Le groupe Point72 a déclaré une participation passive 13G dans Invivyd, Inc. Le dépôt indique que Point72 Asset Management, Point72 Capital Advisors et Steven A. Cohen détiennent à titre bénéficiaire 16 730 467 actions, représentant 8,0 % du capital social ordinaire d'Invivyd sur la base de 209 377 291 actions en circulation après l'offre souscrite de l'émetteur du 22 août 2025. Les actions déclarées sont détenues via Point72 Associates, LLC, avec des pouvoirs de vote et de disposition partagés et aucun pouvoir exclusif de vote ou de disposition déclaré. Le dépôt est effectué conjointement et précise que la position n'a pas pour but d'influencer le contrôle de l'émetteur.

Die Point72-Gruppe meldete eine passive 13G-Beteiligung an Invivyd, Inc. Die Einreichung weist aus, dass Point72 Asset Management, Point72 Capital Advisors und Steven A. Cohen wirtschaftlich 16.730.467 Aktien besitzen, was 8,0% des ausstehenden Stammkapitals von Invivyd entspricht, basierend auf 209.377.291 ausstehenden Aktien nach dem durch das Emissionshaus am 22. August 2025 durchgeführten gezeichneten Angebot. Die gemeldeten Aktien werden über Point72 Associates, LLC gehalten, mit geteilten Stimm- und Verfügungsrechten und ohne alleiniges Stimm- oder Verfügungsrecht. Die Meldung erfolgt gemeinschaftlich und erklärt, dass die Position nicht dazu bestimmt ist, die Kontrolle über den Emittenten zu beeinflussen.

Positive
  • Material institutional interest disclosed: Point72 group reports an 8.0% stake, which is a clear sign of significant investor interest.
  • Passive intent stated: Filing is on Schedule 13G and includes a certification that the shares were not acquired to change or influence control, reducing immediate governance uncertainty.
Negative
  • None.

Insights

TL;DR: Point72 reports an 8.0% passive stake in Invivyd, disclosed via a joint Schedule 13G.

Point72 affiliates and Steven A. Cohen report beneficial ownership of 16,730,467 shares, equal to 8.0% of the company based on the post-offering share count provided in the filing. The ownership is reported as shared voting and dispositive power with no sole control, and the filing expressly characterizes the stake as not intended to change or influence control. For investors, a disclosed >5% passive stake from a large asset manager is material because it signals institutional interest without an active control intent.

TL;DR: Joint 13G shows coordinated reporting by related Point72 entities and Mr. Cohen, indicating common control but passive intent.

The Schedule 13G is filed jointly by Point72 Asset Management, Point72 Capital Advisors and Steven A. Cohen, and includes a Joint Filing Agreement (Exhibit 99.1). The cover-page details report 0 sole voting/dispositive power and 16,730,467 shared voting/dispositive power, consistent with collective advisory control over fund holdings rather than direct personal ownership. The certification confirms the shares were not acquired to influence control, which is the key distinction between a 13G and a 13D filing.

Il gruppo Point72 ha dichiarato una partecipazione passiva 13G in Invivyd, Inc. La comunicazione indica che Point72 Asset Management, Point72 Capital Advisors e Steven A. Cohen beneficamente possiedono 16.730.467 azioni, pari al 8,0% del capitale sociale ordinario di Invivyd, calcolato su 209.377.291 azioni in circolazione dopo l'offerta sottoscritta dell'emittente del 22 agosto 2025. Le azioni segnalate sono detenute tramite Point72 Associates, LLC, con poteri condivisi di voto e di disposizione e senza poteri esclusivi di voto o di disposizione. La segnalazione è presentata congiuntamente e specifica che la posizione non è intesa a influenzare il controllo dell'emittente.

El grupo Point72 divulgó una participación pasiva 13G en Invivyd, Inc. La presentación muestra que Point72 Asset Management, Point72 Capital Advisors y Steven A. Cohen poseen de forma beneficiaria 16.730.467 acciones, que representan el 8,0% del capital social ordinario de Invivyd sobre la base de 209.377.291 acciones en circulación tras la oferta suscrita del emisor del 22 de agosto de 2025. Las acciones informadas se mantienen a través de Point72 Associates, LLC, con poder de voto y disposición compartidos y sin poder exclusivo de voto o disposición. La presentación se realiza de forma conjunta y declara que la posición no pretende influir en el control del emisor.

포인�72 그룹� 인비비드(Invivyd, Inc.)� 대� 수동� 13G 지분을 공시했습니다. 제출 서류� 따르� Point72 Asset Management, Point72 Capital Advisors � Steven A. Cohen은 � 16,730,467주를 실질적으� 보유하고 있으�, 이는 2025� 8� 22� 발행회사� 인수주식공개(언더라이터드 오퍼�) 이후 기준 발행주식� 209,377,291주를 기준으로 인비비드 보통� 발행주식� 8.0%� 해당합니�. 보고� 주식은 Point72 Associates, LLC� 통해 보유되며 투표권과 처분권은 공동으로 행사되며 단독 투표권이� 단독 처분권은 보고되지 않았습니�. � 제출은 공동으로 이루어졌으며 해당 지분이 발행회사� 지배에 영향� 미치려는 의도� 없다� 명시하고 있습니다.

Le groupe Point72 a déclaré une participation passive 13G dans Invivyd, Inc. Le dépôt indique que Point72 Asset Management, Point72 Capital Advisors et Steven A. Cohen détiennent à titre bénéficiaire 16 730 467 actions, représentant 8,0 % du capital social ordinaire d'Invivyd sur la base de 209 377 291 actions en circulation après l'offre souscrite de l'émetteur du 22 août 2025. Les actions déclarées sont détenues via Point72 Associates, LLC, avec des pouvoirs de vote et de disposition partagés et aucun pouvoir exclusif de vote ou de disposition déclaré. Le dépôt est effectué conjointement et précise que la position n'a pas pour but d'influencer le contrôle de l'émetteur.

Die Point72-Gruppe meldete eine passive 13G-Beteiligung an Invivyd, Inc. Die Einreichung weist aus, dass Point72 Asset Management, Point72 Capital Advisors und Steven A. Cohen wirtschaftlich 16.730.467 Aktien besitzen, was 8,0% des ausstehenden Stammkapitals von Invivyd entspricht, basierend auf 209.377.291 ausstehenden Aktien nach dem durch das Emissionshaus am 22. August 2025 durchgeführten gezeichneten Angebot. Die gemeldeten Aktien werden über Point72 Associates, LLC gehalten, mit geteilten Stimm- und Verfügungsrechten und ohne alleiniges Stimm- oder Verfügungsrecht. Die Meldung erfolgt gemeinschaftlich und erklärt, dass die Position nicht dazu bestimmt ist, die Kontrolle über den Emittenten zu beeinflussen.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/27/2025
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/27/2025
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:08/27/2025
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

FAQ

How many Invivyd (IVVD) shares does Point72 report owning?

Point72 Asset Management, Point72 Capital Advisors and Steven A. Cohen report beneficial ownership of 16,730,467 shares of Invivyd common stock.

What percentage of Invivyd does the 13G filing report?

The filing reports ownership equal to 8.0% of the outstanding shares, based on 209,377,291 shares outstanding after the August 22, 2025 offering.

Is Point72 seeking to influence control of Invivyd according to the filing?

No. The Schedule 13G includes a certification that the securities were not acquired and are not held to change or influence control of the issuer.

Through what vehicle are the shares held?

The shares are held by Point72 Associates, LLC, an investment fund managed by Point72 Asset Management, with Cubist Systematic Strategies, LLC and Point72 Asia (Singapore) Pte. Ltd. acting as sub-advisors for portions of the shares.

Who signed the Schedule 13G on behalf of Point72?

The filing is signed by Jason M. Colombo as Authorized Person for Point72 Asset Management and Point72 Capital Advisors, and on behalf of Steven A. Cohen, dated August 27, 2025.
Invivyd

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Latest SEC Filings

IVVD Stock Data

67.24M
145.27M
41.36%
57.5%
2.77%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
WALTHAM